Holger Thiele

Showing 1-19 of 19 articles

TAVI and horizontal aorta: a "no impact" relationship?

Abdel-Wahab M, Kitamura M, Thiele H

October 4, 2019 | 10.4244/EIJV15I9A136

Reply to the letter to the editor "The impact of chronic total occlusion in non-infarct-related coronary arteries"

Saad M, Fuernau G, Eitel I, Thiele H

June 12, 2019 | 10.4244/EIJ-D-18-00787R

Interventions for valvular disease

Transcatheter treatment of tricuspid regurgitation using edge-to-edge repair: procedural results, clinical implications and predictors of success

Lurz P, Besler C, Noack T, Forner AF, Bevilacqua C, Seeburger J, Rommel K-P, Blazek S, Hartung P, Zimmer M, Mohr F, Schuler G, Linke A, Ender J, Thiele H

June 14, 2018 | 10.4244/EIJ-D-17-01091

Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial

Saad M, Fuernau G, Desch S, Eitel I, de Waha S, Poss J, Ouarrak T, Schneider S, Zeymer U, Thiele H

June 14, 2018 | 10.4244/EIJ-D-17-00451

Mechanical circulatory support: the last resort in cardiogenic shock?

Thiele H, Desch S, de Waha S

April 6, 2018 | 10.4244/EIJV13I18A344

Coronary interventions

ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis

Orban M, Limbourg T, Neumann F-J, Ferenc M, Olbrich H-G, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Poss J, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H, Hausleiter J

December 9, 2016 | 10.4244/EIJY15M12_04

Percutaneous left ventricular assist devices

Thiele H, Fuernau G, Fischer J, Schuler G

November 16, 2016

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock – results from a real-world cohort

de Waha S, Fuernau G, Eitel I, Desch S, Thiele H

June 20, 2016 | 10.4244/EIJV12I3A71

Interventions for heart failure

Percutaneous ventricular assist devices and extracorporeal life support: current applications

Blumenstein J, de Waha S, Thiele H

May 16, 2016 | 10.4244/EIJV12SXA12

Interventions for valvular disease

Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence

Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H

May 16, 2016 | 10.4244/EIJV12I1A17

Coronary interventions

How should I treat a massive left main coronary artery thrombosis in a 49-year-old woman in the context of cardiogenic shock?

Marchese A, Paradies V, Basile M, Iorio E, Palmiotto A, Fiore F, Musumeci G, de Waha S, Thiele H, Wan S, Yaku H

April 8, 2016 | 10.4244/EIJV11I14A321

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort

de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H

March 18, 2016 | 10.4244/EIJV11I12A265

Incidence, predictors, and treatment options of critical limb ischaemia after use of collagen plug-based vascular closure devices

Amer O, Binger S, Desch S, Harnoss H, Schuler G, Thiele H, Eitel I

November 20, 2015 | 10.4244/EIJV11I7A166

Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry

Zeymer U, Hochadel M, Thiele H, Andresen D, Schühlen H, Brachmann J, Elsasser A, Gitt A, Zahn R

July 20, 2015 | 10.4244/EIJY14M08_04

Incidence, characteristics and functional implications of cerebral embolic lesions after the MitraClip procedure

Blazek S, Lurz P, Mangner N, Fuernau G, Seeburger J, Luecke C, Gutberlet M, Ender J, Desch S, Eitel I, Schuler G, Thiele H

February 20, 2015 | 10.4244/EIJY14M05_10

Shock management in acute myocardial infarction

Poss J, Desch S, Thiele H

August 19, 2014 | 10.4244/EIJV10STA12

Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials

Piccolo R, Eitel I, Iversen A, Gu Y, Dominguez-Rodriguez A, de Smet B, Mahmoud K, Abreu-Gonzalez P, Thiele H, Piscione F

January 20, 2014

Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial

Heeger C-H, Jaquet K, Thiele H, Zulkarnaen Y, Cuneo A, Haller D, Kivelitz D, Schmidt T, Krause K, Metzner A, Schneider C, Kuck K-H, Bergmann M

October 26, 2012 | 10.4244/EIJV8I6A113

Tools & Techniques: Percutaneous left ventricular assist devices

Thiele H, Fürnau G, Fischer J, Schuler G

September 30, 2011 | 10.4244/EIJV7I5A101

Latest news

New issue

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Free Access

New this week: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Editorial

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Free Access

Last week's JAA's: 3D printing in TAVI, QFR SYNTAX score and non-obstructive disease

October 8, 2019

Free access

The EuroIntervention health check 2019

October 4, 2019

Holger Thiele

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke